COVID-19: Advice for residents of Noord-Brabant RIVM advises residents of the province of Noord-Brabant to limit their social contacts if they have a cold, cough or a fever. This means: stay at home.
Patient with novel coronavirus deceased An 86-year-old man who was hospitalised in the Ikazia hospital Rotterdam with COVID-19 has died. The source of infection of the patient remains unknown.
Eight new patients, Maasstad Hospital closes ICU department To date, Monday 2 March, eight new patients have been reported to RIVM. This brings the total number of positive tests in the Netherlands to 18.
Three new patients with novel coronavirus (COVID-19) Three new patients were diagnosed with the novel coronavirus (COVID-19) on March 1st, bringing the number of coronavirus patients in the Netherlands to ten.
Patient with COVID-19 in Delft On 29 February, a woman in Delft was diagnosed with the novel coronavirus (COVID-19) in the Netherlands. The woman had been in Lombardy, in Northern Italy, last week.
Application of personalised medicine: opportunities and challenges Pharmacotherapy based on individual patient characteristics such as genetic makeup, offers many potential benefits towards more effective treatment of a patients’ disease.
Strict diet combats aging diseases Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want.
Improved protection against pertussis The international PERISCOPE project has been granted a 30 million Euro European subsidy in order to better map the immune response to pertussis infection and vaccination.
Chikungunya infections in the Caribbean region Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.
Dr. Els van Schie new director of Environment and Safety Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.